Henry Ford Hospital Medical Journal
Volume 40

Number 3

Article 10

9-1992

Hyperparathyroidism with Normal Albumin-Corrected Total
Calcium in Patients with Multiple Endocrine Neoplasia Type 1
J. J. Shepherd
Bin Tean Teh
V. Parameswaran
R. David

Follow this and additional works at: https://scholarlycommons.henryford.com/hfhmedjournal
Part of the Life Sciences Commons, Medical Specialties Commons, and the Public Health Commons

Recommended Citation
Shepherd, J. J.; Teh, Bin Tean; Parameswaran, V.; and David, R. (1992) "Hyperparathyroidism with Normal
Albumin-Corrected Total Calcium in Patients with Multiple Endocrine Neoplasia Type 1," Henry Ford
Hospital Medical Journal : Vol. 40 : No. 3 , 186-190.
Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol40/iss3/10

This Article is brought to you for free and open access by Henry Ford Health System Scholarly Commons. It has
been accepted for inclusion in Henry Ford Hospital Medical Journal by an authorized editor of Henry Ford Health
System Scholarly Commons.

Hyperparathyroidism with Normal Albumin-Corrected Total
Calcium in Patients with Multiple Endocrine Neoplasia Type 1

J. J. Shepherd,* Bin Tean Teh,* V. Parameswaran,* and R. David'

In the largest reported family of patients with multiple endocrine neoplasia type 1 (MEN 1],
hyperparathyroidism was expressed atfirstscreening in 33 patients by elevation of ionized calcium
(IC) (30 cases) or parathyroid hormone (three cases) without elevation of albumin-corrected total
calcium (ACTC). Three ofthese 33 patients have shown a progressive rise in IC and later an elevation
of ACTC. However, the age distribution suggests that in others the level ofIC may remain stable at a
minimally elevated level throughout life with ACTC remaining normal exceptfor transient rises at the
times of intercurrent illness or surgical operation. Even when ACTC is normal preoperatively,
patients with an elevation of IC require radical subtotal parathyroidectomy or total parathyroidectomy and forearm implantation to restore IC to a normal level. Institutions that rely on ACTC
as a screening testfor hyperparathyroidism in MEN I will miss the diagnosis in nearly half ofpatients
under the age of 30. The greatest deficiency in using ACTC occurs in the follow-up of patients who
have undergone parathyroidectomy for MEN I. Only three of 11 recurrences were evidenced by this
measurement. (Henry Ford Hosp Med J 1992:40:186-90)

number of authors (1-3) have suggested that ionized serum calcium (IC) may be a better discriminant or elevated
more consistendy than albumin-corrected total serum calcium
(ACTC) or parathyroid hormone (PTH) in patients with hyperparathyroidism. Previous studies have dealt predominantly with
middle-aged or elderly patients. The presence of a large family
(4) of patients in Tasmania with multiple endocrine neoplasia
type 1 (MEN 1) has made it possible to screen large numbers of
young patients who are at 50% risk of developing parathyroid
hyperplasia, as weU as more elderly patients with established
disease. In the early years of this study, only the total serum calcium was measured and corrected for albumin. At the end of
1986 an analyzer for ionized calcium (Radiometer, Copenhagen) was installed, and in all subsequent screenings at the
Royal Hobart Hospital both total and ionized fractions have
been measured.
A total of 93 members of one family with MEN 1 had shown
biochemical evidence of hyperparathyroidism by the end of
1990. In 60 patients this was associated at first screening with elevations of ACTC. However, in 33 patients (35%), ACTC was
found to be normal at first screening. Three of those seen before
1986 were considered to have hyperparathyroidism on the basis
of elevation of PTH. In one patient this was confirmed at neck
exploration. After measurement of IC became available, the
other two patients with elevated PTH but normal ACTC were
found to have elevated IC and another 30 patients were identified with normal ACTC but elevated IC. Most of these had normal PTH. In some of these patients ACTC was toward the upper
end of the normal range, but in others it was around the midpoint
and in a few toward the lower limit of the normal range. It was
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apparent that the acceptance of IC, rather than ACTC, as a
screening test would result in a substantial increase in numbers
of patients diagnosed as having MEN 1. We therefore decided to
review these patients and assess the supporting evidence from
other sources for the diagnosis of hyperparathyroidism and
MEN 1 in order to justify a change from the traditional standard
of elevated ACTC as the basis of diagnosis.
Patients with elevated ACTC have been compared to those
with normal ACTC but raised IC or PTH in terms of age, association with other manifestations of MEN 1, parentage of affected
offspring, renal and bone involvement, operative findings, and
results of surgery.

Results
Age
Elevation of ACTC was seen in MEN 1 patients of all age
groups, with an age range of 11 to 75 years at first diagnosis (Table 1). Elevation of IC with normal ACTC was also seen in
MEN 1 patients in all age groups (age range of 13 to 81 years at
first diagnosis) but was more predominant in young patients. Up
to the age of 30 years, almost half of all patients with elevated IC
have normal ACTC. Above the age of 30, die majority of patients with elevated IC also have elevated ACTC, but even in
this group 28% have normal ACTC.
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Association with lesions at other sites
Thirty-three (55%) of the 60 patients with elevated ACTC
also had evidence of a lesion of the pancreas, pituitary, or adrenal or an intrathoracic carcinoid tumor. Seventeen (52%) of the
33 patients with elevated PTH or IC but normal ACTC had evidence of an endocrine tumor at another site.
Experience of the Zollinger-Ellison (ZE) syndrome in Tasman Family 1 has been the same as that reported in an English
family (5) where the syndrome only presented in patients who
had elevation of semm calcium and semm gastrin. In four of our
symptomatic patients, however, this would not have been detected if the IC had not been measured, because these patients
had elevated IC but normal ACTC. All of these patients have undergone neck exploration, and all were found to have four-gland
hyperplasia. Restoration of IC to normal levels has resulted in
symptomatic improvement and a fall in the level of serum gastrin.
Parenthood
Thirty-three of the patients with elevated ACTC are 35 years
old or older. Twenty-three (70%) of these 33 have affected children. Sixteen of the patients with elevated IC but normal ACTC
are 35 years or older. Nine (56%) of these 16 have affected children diagnosed with MEN 1.
Patient 646 in Tasman Family 1 genealogy 9 had seven sons
and two daughters (4). He had normal prolactin, normal gastrin,
and normal ACTC at first testing in 1984. IC was first estimated
in 1987 when this patient was 81 years old and was found to be
elevated although ACTC remained normal. One son (patient
1548) developed "fits" at the age of 19 which was diagnosed as
epilepsy. Over the next 12 years, he spent long periods under
psychiatric care and off work. Ultimately surgical exploration
revealed an insulinoma and two other adenomas in the pancreas.
This resolved his medical and psychiatric problems. Although a
daughter (patient 1551) was asymptomatic at first screening for
MEN 1, she was found to have gross elevation of serum gastrin
and semm prolactin. Computed tomography showed liver metastasis and erosion of the pituitary fossa. Another son (patient
1553) had raised ACTC, raised gastrin, and an adrenal adenoma
at first screening. Four of the grandchildren also are clearly affected with three showing lesions of the pancreas and pituitary
in addition to hyperparathyroidism.
Renal and bone involvement
Eight of the patients with raised ACTC had renal calculi. Four
of these had nephrocalcinosis and one developed widespread
cystic bone disease (the single instance of this complication in
93 patients).
Only two of the patients with elevated IC but normal ACTC
developed renal calculi; neither of these patients has nephrocalcinosis. However, the case records of one of the patients with
raised ACTC—patient 1757 bom in 1939 and fully investigated
in a urology service in 1965 and 1971—clearly show that he developed multiple calculi and bilateral nephrocalcinosis at a time
when measurement of ACTC was within the normal range. Following right renal calculus in 1971, he developed left renal calculus in 1972 and had partial nephrectomy for nephrocalcinosis
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Table 1
Age at Diagnosis of 93 Patients
with Elevated Serum Calcium
Age (years)
10-19
20-29
30-39
40-49
50-59
60-69
70-1Total

Elevated ACTC

Normal ACTC Elevated IC

5
14
16
11
7
6
1
60

6
11
4
6
3
2
1
33

in 1973. On each occasion the case records show that the diagnosis of hyperparathyroidism was considered but that the level
of ACTC was found to be normal. In 1971, it was 9.3 mg/dL
(normal 9.0 to 11.4 mg/dL). His family history was not known
until 1983 when he was first screened for MEN 1. This revealed
gross elevation of serum prolactin at 184 ug/L (normal 11 (ig/L)
and elevation of ACTC at 2.73 mmol/L (normal 2.10 to 2.60
mmol/L). Ionized calcium was not being measured in 1983, but
it is highly likely from our experience with other family members that elevation of IC was present from an early age and at the
time that his renal problems developed. One of his children, age
19 years, has a prolactinoma of the pituitary, an adenoma of the
pancreas, and elevation of IC but not of ACTC or PTH.
At the age of 44, patient 1757 had ischemic heart disease and
hypertension which progressed despite parathyroidectomy. At
the age of 49 he had a debilitating stroke and hemiparesis.
Findings at surgery
A total of 54 neck explorations have been conducted in 48
members of Tasman Family 1. Overall, 44 patients had a single
neck exploration, three patients had two explorations, and one
patient had four explorations.
On 40 occasions surgery was indicated on the basis of symptoms associated with elevated ACTC, but 14 patients had normal ACTC and elevation only of IC. In 39 of the 40 operations
associated with elevation of ACTC, hyperplasia of all glands
was either identified at operation or indicated by persistence of
hypercalcemia after removal of less than 3.5 glands. In one patient removal of a single enlarged gland has been followed by
prolonged restoration of normal calcium levels.
Seven of the patients with elevated ACTC had parathyroid
glands larger than 3 cm in diameter, and one patient had five of
eight enlarged parathyroids in excess of 3 cm and two in excess
of 5 cm in diameter.
On 14 occasions, surgery has been carried out on patients who
had normal ACTC but either elevated IC or elevated PTH. Hyperplasia of all four glands was identified at first exploration in
all 14 patients. Only one patient in this group had a parathyroid
exceeding 2 cm in diameter.
Results of surgery
Ten of the 54 neck explorations were carried out elsewhere.
Nine of these were performed at major teaching hospitals but on
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Table 2
Results of Surgery in MEN 1 (44 Operations, 42 Patients)

Preoperative
elevation ACTC
Preoperative
elevation IC
normal ACTC

Postoperative Elevation IC
Normal ACTC

Total

Postoperative
Elevation ACTC

30

3

(.

14

(1

2

six occasions the diagnosis was simply primary hyperparathyroidism and the surgeon was unaware that the patient had MEN
1. After nine of these 10 operations, postoperative ACTC measurements showed persistent or recurrent elevation of ACTC.
We have been unable to obtain a record of the postoperative calcium levels in one case.
There has not been a single negative neck exploration in a
member of this family. At least one abnormal parathyroid has
been identified on every occasion, regardless of whether the diagnosis was based on elevation of ACTC, PTH, or IC.
Forty-four neck explorations for hyperparathyroidism in 42
patients with MEN 1 from Tasman Family 1 have been carried
out in the Royal Hobart Hospital. On 30 occasions both ACTC
and IC were elevated. On 14 occasions patients had normal
ACTC but elevated IC or PTH preoperatively. In follow-up
varying from 1 to 16 years, persistent or recurrent elevation of
ACTC has occurred only three times. On measurement of IC, a
further eight patients have persistent elevations although ACTC
is normal. Six of these are patients who had elevation of ACTC
preoperatively. Subtotal parathyroidectomy has restored ACTC
to normal levels but IC remains elevated. Two of these are patients whose ACTC was normal preoperatively. Therefore, in
these two cases, measurement of ACTC showed normal levels
both before and after surgery whereas measurement of IC
showed elevated levels both before and after the identification
and excision of 3.5 parathyroids (Table 2).

Progress of untreated patients
The majority of patients have been followed for more than
three years. Three patients under the age of 30 with normal
ACTC but elevated IC at the time of their initial test subsequently showed a rise both in IC and ACTC. In 27 patients, the
situation of elevated IC but normal ACTC has been maintained
at subsequent testing. A transient exception to this pattem has
been observed in our patients during operation or intercurrent
illness. The calcium has been monitored in one patient undergoing surgery for testicular torsion, in one patient during hysterectomy for fibroids, in one patient hospitalized for renal colic, and
in one patient admitted for the treatment of pneumonia. In each
ofthese patients ACTC became transiently elevated during their
illness or operation but retumed to normal levels following resolution of the illness or recovery from operation. IC levels remained elevated throughout.
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Table 3
Supporting Evidence for MEN 1 in 93 Patients with
Elevated Serum Calcium
Elevated ACTC
Lesions at other sites
Affected offspring
Confirmed by surgery
or autopsy
Lesions at other sites and/or
affected offspring and/or
confirmed by surgery
Total

Normal ACTC Elevated IC

44 (73%)
23

23 (70%)
9

34 (57%)

15 (45%)

44 (73%)
60

23 (70%)
33

Discussion
Benson and colleagues (2) reported in 1987 following a study
of three discriminants that IC is a more sensitive predictor of primary hyperparathyroidism than either ACTC or PTH. PTH
assays have not been consistently valuable in our study. In the
early years, the measurement of C-terminal was used and considered to be unsatisfactory. Later, the introduction of measuring the intact molecule proved to be not always helpful in young
patients with MEN 1 who have elevated ACTC or IC. Even a
normal level of PTH is inappropriate in these patients and the
diagnosis of hyperparathyroidism would only be considered
doubtful if PTH were low or absent.
Altogether, 23 (70%) of the 33 patients with elevated IC either have additional evidence of MEN 1 in terms of having another neuroendocrine lesion or having children with other neuroendocrine lesions or else have had the diagnosis of hyperparathyroidism confirmed by surgery. This is virtually identical
with the findings in those with elevated ACTC (Table 3). We
conclude that the diagnosis of MEN 1 is just as probable in patients with elevated IC but normal ACTC as in those with elevated ACTC.
It has only been possible to measure IC since the end of 1986
and a larger study and prolonged follow-up is necessary to provide firm conclusions regarding the emerging pattem of calcium
changes and PTH levels in teenagers as hyperparathyroidism
develops. Initial results suggest that it is the normal pattem for
IC to become elevated whilst both ACTC and PTH are within
the normal range. We have not seen any patients with consistent
elevation of ACTC but normal IC. With the passage of time,
some patients progress to a situation where both ACTC and IC
are elevated. In other patients IC is persistently elevated but
ACTC remains normal throughout life except during periods of
illness or stress.
Moreover, the age distribution of elevated IC with normal
ACTC (Table 1, Figure) indicates that if screening is based on
ACTC then diagnosis may not simply be delayed but may never
be establi.shed. Offspring may then be unaware of their family
history. It is inconceivable that the diagnosis of insulinoma
would have been missed for 12 years if patient 1548 had given a
family history of hyperparathyroidism. Careful assessment of
the pancreas, pituitary, adrenal, thymus, and bronchus where
more serious lesions may develop will be omitted.
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Failure to measure IC may adversely affect the management
of intractable ulceration in patients with MEN 1. In this family,
every patient with the ZE syndrome and raised serum gastrin
also has an elevation of the serum calcium, but in four ofthe patients only IC was elevated and ACTC was normal. In these four
patients, previously intractable ulceration responded to parathyroidectomy without the necessity for gastric surgery. On the
other hand, a member of Tasman Family 1 who had migrated to
another country underwent three major gastric operations, culminating in total gastrectomy for bleeding ulcer without recognition ofher parathyroid hyperplasia. She is not included in our
series of 93 patients because IC was never measured and ACTC
was normal. She clearly had hyperparathyroidism because at her
death from metastasizing malignant carcinoid of the bronchus,
postmortem revealed four hyperplastic parathyroid glands up to
2 cm in diameter. A previous history of adrenal and pituitary
adenomas had alerted her physicians to the likelihood of MEN
1, but when both ACTC and PTH were found to be normal they
considered the diagnosis of hyperparathyroidism as unproven.
Our experience suggests that her IC would have been elevated
had this measurement been undertaken and her intractable ulcer
would probably have responded to parathyroidectomy. Incidentally, this case history indicates that the finding of normal
ACTC and PTH in the presence of indisputable hyperparathyroidism in a member of this family is not confined to our institution.
An unwelcome aspect of this study from the surgical viewpoint has been the finding that recurrence or persistence of hypercalcemia after parathyroidectomy is much more common
than is apparent when only ACTC is measured. Rather than
three recurrences in patients from our own unit identified on the
basis of ACTC measurement, il has been found that IC remains,
or has again become, elevated in 11 of 44 operations. Our initial
experience of finding moderately enlarged glands, compared
with those found in patients with elevation of ACTC, led to an
earlier philosophy in the patients with normal ACTC of preserving the equivalent of one small gland to avoid hypoparathyroidism. It has now become apparent that these patients need to
be dealt with just as radically as those with elevation of ACTC
or elevation of IC will persist or recur.
Several studies have reported a higher recurrence rate following parathyroid surgery in patients with MEN 1 than in those
with adenomas or hyperplasia from other causes. Following ten
operations on members of this family outside our own unit, the
recurrence rate has been at least 90%. Prinz et al (6) found a recurrence rate of 33% whilst Rizzoli et al (7) reported 54% recurrence after one operation and 46% after a second neck exploration in MEN 1 patients.
All previous authors appear to have based their figures entirely on the measurement of ACTC. Our experience suggests
that the true recurrence rate may be much higher than even the
unsatisfactory levels indicated by previous studies and that a
radical surgical approach is essential in all patients with MEN 1.
However, the main significance of the operative findings and
postoperative .studies may be the indication that elevation of IC
with normal ACTC reflects to some extent the quantity of
hyperplastic parathyroid tissue. Measurement of ACTC estab-
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Figure—Age grouping: The designated "elevated IC" group indicates those with elevated IC hut normal ACTC.

lishes the diagnosis of hyperparathyroidism in one-half of patients under the age of 30 and 65% at all ages when four hyperplastic glands are present. However, measurement of ACTC
will only establish the diagnosis in one-fourth of patients with
persistent hyperparathyroidism associated with one or less than
one hyperplastic gland. If a similar situation applies to the early
stages of sporadic adenomas, it is possible that ACTC is equally
unsuitable to screen members of the general population with renal calcuh, osteopenia, or recurrent pancreatitis.
The finding that many MEN 1 patients have normal ACTC
should not be interpreted as indicating that only a modest level
of hypercalcemia is a constant finding in the syndrome. Three
patients had ACTC levels between 3.5 and 3.9 mmol/L at first
diagnosis with two requiring urgent treatment of acute hypercalcemic crisis. Moreover, a sudden rise of IC and a transient rise of
ACTC have been observed in four patients after operation or
during intercurrent illness, reinforcing the view that in MEN 1
families it is highly desirable to identify all patients with hyperparathyroidism by including the measurement of IC in routine
screening.
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